Oscar Health (OSCR) Enterprise Value (2021 - 2026)

Oscar Health (OSCR) has reported Enterprise Value for 6 consecutive years, with -$754.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value fell 160.61% year-over-year to -$754.7 million; the trailing twelve-month figure through Jun 2026 stood at -$754.7 million (down 160.61% YoY), and the FY2025 full-year result was -$224.7 million, down 130.35% from the prior year.
• Enterprise Value grew to -$754.7 million in Q2 2026 per OSCR's latest filing, from -$3.8 billion in the prior quarter.
• Across five years, Enterprise Value topped out at $2.8 billion in Q3 2024 and bottomed at -$3.8 billion in Q1 2026.
• Historically, Enterprise Value has averaged -$702.7 million across 5 years, with a median of -$769.4 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Enterprise Value tumbled 7125.46% in 2022, then surged 301.72% in 2024.
• Over 5 years, Enterprise Value stood at -$2.5 billion in 2022, then jumped by 68.74% to -$784.0 million in 2023, then surged by 194.44% to $740.4 million in 2024, then sank by 130.35% to -$224.7 million in 2025, then slumped by 235.84% to -$754.7 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$754.7 million, -$3.8 billion, and -$224.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.